AimwellBio Cohort 01 · Applications Open
The Founding Invitation

The verified network is open.

AimwellBio is inviting ten founding health experts to help define how human authority appears in the AI answer era.

Physicians · Researchers · Scientists · Chiropractors

Request Founding Consideration
A physician walking toward an open doorway of light.

10Seats

The Shift

Search ranked websites. AI recommends people.

Millions of Americans now take GLP-1 medications, and millions more are asking whether they should. It is the fastest consumer shift in modern medicine, and it has outrun the systems meant to keep it safe: gray-market sourcing, unverified advice, and an internet full of confident answers with no credentials behind them.

AimwellBio believes the next phase of this era belongs to verified physicians.

0102030405
What Founding Physicians Receive

At no cost.

Three founding physicians.
Physicians · Researchers · Scientists · Chiropractors
01

A verified physician profile

Credential-based verification on the AimwellBio platform, structured so answer engines can find, understand, and cite it.

02

Editorial and press visibility

Features through the Company's established newswire and social channels.

03

FHIN membership

Membership in the Federated Health Intelligence Network.

04

A research command center

A personalized workspace that assembles your literature, signals, and evidence in one place.

05

First-priority practice path

A first-priority path to a turnkey virtual practice as the telemedicine capability activates.

Planned Programs

Three areas of physician-directed care.

01 GLP-1 and metabolic care The fastest-moving category in consumer medicine, and the one most in need of verified clinical authority.
02 Hormone and menopause health Care pathways for women and men, directed by licensed physicians.
03 Physician-directed injectable and peptide therapies Prescribed by independent licensed physicians only where clinically appropriate and permitted by law.
The Application

Ten seats. Credentials are the only requirement to apply.

Verification cannot be purchased. No payment of any kind influences clinical standing, recommendations, prescribing, or patient routing.

This is an application, not an enrollment. Founding participation is reviewed against credentials.

Do not include patient information. This form collects professional credentials only. Never submit symptoms, medications, diagnoses, or any patient or personal health history.

We will ask for the rest by reply. Headshot, bio, publications, press history and profile links are easier to send as an email than to type into a form. Nothing beyond credentials affects whether you are considered.

Questions? corporate@aimwellbio.com

Optional. This is the single most useful thing you can tell us. It shapes how we position you across profiles, press, and AI answer surfaces.

Your submission is confidential and is used only to review your application. Not every applicant is accepted.

Application received.

Your founding application has been submitted. A member of the team reviews every submission personally and will respond directly.

If you do not hear back, write to corporate@aimwellbio.com.

Forward-looking statements. This page contains forward-looking statements regarding planned capabilities, including telemedicine integration and related programs. Such statements are not guarantees of future performance and involve risks and uncertainties. Planned programs are subject to regulatory requirements, and any care would be delivered by independent licensed physicians only where clinically appropriate and permitted by law. Actual results may differ materially.

Verification on the AimwellBio platform is credential-based and cannot be purchased. No payment of any kind influences clinical standing, recommendations, prescribing, or patient routing. This page does not provide medical advice.

Aimwell Partners Inc. (OTCID: AIMN)